Back | Next |
home / stock / rcel / rcel message board
Subject | By | Source | When |
---|---|---|---|
Let's hope this is just the beginning of | pick | investorshub | 02/24/2023 3:22:56 PM |
The Aussie stock is up 21.67% so far tonight. | Fmello | investorshub | 02/24/2023 1:53:16 AM |
Webinar link @4:30PM ET on 2/23/23 | Cake10 | investorshub | 02/23/2023 9:29:01 PM |
Bada bing bada boom! | Cake10 | investorshub | 02/23/2023 9:26:48 PM |
I have 2/23 after hours. | MONYMAN3 | investorshub | 02/06/2023 5:30:11 PM |
Thanks when is the next earnings report | Spetch | investorshub | 02/06/2023 5:06:54 PM |
For me, I'd like to see an increase | MONYMAN3 | investorshub | 02/06/2023 4:33:41 PM |
Hi guys | Spetch | investorshub | 02/06/2023 3:56:10 PM |
In a report released yesterday, Ryan Zimmerman from | Fmello | investorshub | 01/20/2023 6:46:27 PM |
Looks like some house cleaning is continuing. Both, | veni vidi vici | investorshub | 01/19/2023 10:32:50 PM |
Avita Medical submits FDA PMA application to expand | Fmello | investorshub | 12/18/2022 11:16:23 PM |
Some highlights: | MONYMAN3 | investorshub | 12/18/2022 8:30:48 PM |
The story is behind a paywall. Can someone | Fmello | investorshub | 12/17/2022 9:03:22 PM |
https://seekingalpha.com/article/4564991-avita-micro-cap-with-approvals-on-near- | MONYMAN3 | investorshub | 12/17/2022 6:15:29 PM |
Couple of minor corrections on that summary | Cake10 | investorshub | 12/12/2022 9:39:38 PM |
This appears to be the transcript template for | Cake10 | investorshub | 12/12/2022 9:25:40 PM |
Hopefully, the FDA will expedite and approve it | Fmello | investorshub | 12/12/2022 3:33:32 PM |
AVITA Medical Submits PMA Supplement for Soft Tissue Repair | Fmello | investorshub | 12/12/2022 3:41:18 AM |
Saw this on the Hot Copper boards: | Fmello | investorshub | 12/10/2022 3:34:22 AM |
Nice summary. I wasnt able to attend but | Cake10 | investorshub | 12/07/2022 10:53:12 PM |
News, Short Squeeze, Breakout and More Instantly...
VALENCIA, Calif., July 11, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin restoration, today announced that it will report its second quarter 2024 financia...
VALENCIA, Calif., June 05, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin restoration, today announced that the Joseph M. Still Burn Center at Doctors Hosp...
2024-06-02 14:14:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...